Massimo Pinzani
Overview
Explore the profile of Massimo Pinzani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
207
Citations
9446
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Marchesini G, Vettor R, Pinzani M
J Hepatol
. 2024 Jan;
80(2):178-180.
PMID: 38278621
No abstract available.
12.
Pinzani M
Clin Gastroenterol Hepatol
. 2023 Dec;
22(8):1584-1585.
PMID: 38147945
No abstract available.
13.
Parola M, Pinzani M
Mol Aspects Med
. 2023 Dec;
95:101231.
PMID: 38056058
Liver fibrosis, as an excess deposition of extracellular matrix (ECM) components, results from chronic liver injury as well as persistent activation of inflammatory response and of fibrogenesis. Liver fibrosis is...
14.
Roccarina D, Saffioti F, Rosselli M, Marshall A, Pinzani M, Thorburn D
JHEP Rep
. 2023 Sep;
5(11):100873.
PMID: 37771366
Background & Aims: Liver stiffness measurement (LSM) and spleen stiffness measurement (SSM) have been shown to be useful tools for assessing the risk of fibrosis and portal hypertension, respectively. However,...
15.
Felli E, Felli E, Muttillo E, Urade T, Laracca G, Giannelli V, et al.
Liver Transpl
. 2023 Sep;
29(11):1226-1233.
PMID: 37728488
An ischemia-reperfusion injury (IRI) results from a prolonged ischemic insult followed by the restoration of blood perfusion, being a common cause of morbidity and mortality, especially in liver transplantation. At...
16.
MacKinnon A, Tonev D, Jacoby B, Pinzani M, Slack R
Expert Opin Ther Targets
. 2023 Sep;
27(9):779-791.
PMID: 37705214
Introduction: The rising incidence of liver diseases is a worldwide healthcare concern. However, the therapeutic options to manage chronic inflammation and fibrosis, the processes at the basis of morbidity and...
17.
Cardinale V, Lanthier N, Baptista P, Carpino G, Carnevale G, Orlando G, et al.
Stem Cell Reports
. 2023 Aug;
18(8):1555-1572.
PMID: 37557073
This review aims to evaluate the current preclinical state of liver bioengineering, the clinical context for liver cell therapies, the cell sources, the delivery routes, and the results of clinical...
18.
Pinzani M
Nat Rev Gastroenterol Hepatol
. 2023 Jul;
20(10):632.
PMID: 37495723
No abstract available.
19.
Greenman R, Segal-Salto M, Barashi N, Hay O, Katav A, Levi O, et al.
JCI Insight
. 2023 Jun;
8(12).
PMID: 37345655
ˆCCL24 is a pro-fibrotic, pro-inflammatory chemokine expressed in several chronic fibrotic diseases. In the liver, CCL24 plays a role in fibrosis and inflammation, and blocking CCL24 led to reduced liver...
20.
Al-Akkad W, Acedo P, Vilia M, Frenguelli L, Ney A, Rodriguez-Hernandez I, et al.
Cells
. 2022 Nov;
11(22).
PMID: 36429078
Over 80% of patients with pancreatic ductal adenocarcinoma (PDAC) are diagnosed at a late stage and are locally advanced or with concurrent metastases. The aggressive phenotype and relative chemo- and...